Course curriculum

    1. Abnormal uterine bleeding - 4Qs (March 2025)

    2. Abnormal uterine bleeding in reproductive-aged women - 2Qs (November 2018)

    3. Adnexal mass in premenopausal women - 2Qs (November 2019)

    4. Amenorrhea - Primary - 2Qs (November 2018)

    5. Amenorrhea - Secondary - 2Qs (September 2018)

    6. Amniotic fluid embolism (May 2019)

    7. Androgenic alopecia (September 2024)

    8. Annual well-woman examination (March 2023)

    9. Antidepressants and sexual dysfunction - 2Qs (May 2020)

    10. Bacterial vaginosis (May 2021)

    11. Bartholin gland abscess - 2Qs (March 2025)

    12. Benefits of breastfeeding - 2Qs (July 2019)

    13. Borderline ovarian tumors - 3Qs (January 2022)

    14. BRCA1/2 gene testing (July 2022)

    15. Breast cancer - chemoprophylaxis - 3Qs (July 2019)

    16. Breast cancer - Genitourinary symptoms - 3Qs (January 2019)

    17. Breast cancer screening - 2Qs (January 2022)

    18. Breast cancer survivors - Chronic side effects - 4Qs (July 2018)

    19. Breast cancer – triple negative - 4Qs (May 2019)

    20. Breast imaging of dense breasts (January 2023)

    21. Cannabis in pregnancy - 2Qs (January 2025)

    22. Cardiomyopathy - peripartum - 2Qs (March 2022)

    23. Cervical cancer screening - 2Qs (UPDATED January 2021)

    24. Cervical cancer screening - 2Qs (September 2018)

    25. Cervical cancer screening after age 65 (UPDATED January 2021)

    26. Cervical cancer screening >65 years (January 2019)

    27. Cervical cancer screening <65 years - 2Qs (January 2019)

    28. Cervical polyps (March 2022)

    29. Cervical polyps (July 2018)

    30. Chest pain in women (September 2023)

    31. Condyloma acuminata - 2Qs (November 2018)

    32. Contraception and cardiovascular disease - 2Qs (May 2019)

    33. Contraception and neurologic disease - 2Qs (March 2019)

    34. Contraception and stroke risk (May 2023)

    35. Contraception in older females - 3Qs (March 2024)

    36. Contraception in older women - 3Qs (January 2021)

    37. Contraception in women with diabetes - 2Qs (May 2019)

    38. Depression in perimenopause (May 2025)

    39. Depression in perimenopause - 2Qs (March 2019)

    40. Discontinuing contraception (January 2021)

    41. Disseminated gonococcal infection - 2Qs (November 2021)

    42. Dysmenorrhea - 2Qs (January 2023)

    43. Dyspareunia - 4Qs (January 2024)

    44. Emergency contraception - 4Qs (May 2019)

    45. Endometrial cancer - 5Qs (November 2020)

    46. Endometrial polyps - 2Qs (March 2023)

    47. Endometriosis - 4Qs (March 2024)

    48. Endometriosis - 2Qs (November 2019)

    49. External cephalic version - 3Qs (July 2023)

    50. Galactorrhea (January 2022)

    51. Galactogogues (November 2022)

    52. Genitourinary syndrome of menopause - 3Qs (May 2025)

    53. Gestational diabetes - screening - 2Qs (November 2021)

    54. Gonorrhea - 3Qs (November 2021)

    55. Hair loss in women - 5Qs (September 2021)

    56. Headache in pregnancy - 3Qs (July 2019)

    57. Healthcare for sexual minority women (May 2024)

    58. High-grade cervical squamous intraepithelial lesion (July 2018)

    59. Hirsutism in women (November 2019)

    60. HIV and contraception (July 2022)

    61. Hormone replacement therapy - 3Qs (March 2024)

    62. Imaging of dense breasts - 2Qs (July 2019)

    63. HSIL - management - 2Qs (September 2024)

    64. Human trafficking - 2Qs (July 2021)

    65. Intrauterine contraception - 2Qs (November 2018)

    66. Intrauterine devices - hormonal (July 2018)

    67. Intrauterine device - insertion - 2Qs (July 2018)

    68. Intrauterine devices - problems/complications (July 2018)

    69. Intrauterine device - removal (July 2018)

    70. Mechanical heart valve and pregnancy - 2Qs (May 2019)

    71. Menopause and depression (July 2023)

    72. Menorrhagia - 3Qs (May 2021)

    73. Menstrual migraine - 2Qs (May 2019)

    74. Natural family planning - 2Qs (May 2025)

    75. Obesity effect on fertility and pregnancy - 2Qs (November 2022)

    76. Oral contraceptives and risk of venous thromboembolism (March 2020)

    77. Over-the-counter progesterone-only OCP (September 2023)

    78. Paget's disease of the breast - 2Qs (September 2021)

    79. Pelvic apophyseal injury (May 2025)

    80. Pelvic inflammatory disease - 3Qs (March 2022)

    81. Pelvic inflammatory disease - 3Qs (November 2021)

    82. Pelvic inflammatory disease - complications - 2Qs (July 2023)

    83. Pelvic organ prolapse - 2Qs (September 2024)

    84. Pelvic pain - chronic 3Qs (January 2025)

    85. Peri and postmenopausal bleeding - 3Qs (November 2018)

    86. Peripheral artery disease - management - 2Qs (January 2025)

    87. Peripheral artery disease in women - 2Qs (January 2025)

    88. Polycystic ovarian syndrome - 2Qs (July 2023)

    89. Postpartum eclampsia (January 2019)

    90. Postpartum thyroiditis (July 2020)

    91. Pregnancy and obesity (May 2019)

    92. Premature ovarian insufficiency - 3Qs (May 2022)

    93. Premenstrual syndrome and premenstrual dysphoric disorder - 3Qs (May 2022)

    94. Premature ovarian insufficiency - 3Qs (July 2020)

    95. Procedures - Choosing Wisely - 5Qs (July 2023)

    96. Progestin-only oral contraceptives (March 2020)

    97. Screening for cervical cancer - 3Qs (July 2023)

    98. Secondary dysmenorrhea (January 2023)

    99. Sleep problems in women (March 2023)

    100. Syphilis in pregnancy - 2Qs (January 2022)

    101. Tamoxifen - 2Qs (November 2022)

    102. Threatened miscarriage (September 2018)

    103. Transgender breast cancer risk and screening (September 2020)

    104. Trichomoniasis - 2Qs (March 2022)

    105. Trichomoniasis (March 2020)

    106. Triple negative breast cancer (September 2021)

    107. Urinary incontinence - 2Qs (November 2018)

    108. Uterine bleeding - Abnormal (September 2018)

    109. Uterine fibroids - 2Qs (March 2025)

    110. Uterine fibroids - 2Qs (January 2019)

    111. UTI in nonpregnant women - 2Qs (March 2020)

About this course

  • Free
  • 111 lessons
  • 0 hours of video content